Abstract
One of the highlights of the antifungal sessions at the ECCMID-ICC congress was the presentation of the first European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline for diagnostic and management for Candida diseases. Experts also discussed specific aspects of the management of invasive fungal disease in the intensive care unit and in hematological malignancy. Data from new clinical studies and from 'real life' experience of clinical use of antifungal therapy were also presented and discussed.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 985-989 |
| Numero di pagine | 5 |
| Rivista | Future Microbiology |
| Volume | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Animals
- Antibiotic Prophylaxis
- Antifungal Agents
- Candida
- Candidiasis, Invasive
- Drug Resistance, Fungal
- Europe
- Hematologic Neoplasms
- Humans
- Intensive Care
- Practice Guidelines as Topic